ACH
ArrowMark Colorado Holdings Portfolio holdings
AUM
$5.55B
1-Year Return
17.42%
This Quarter Return
+1.15%
1 Year Return
+17.42%
3 Year Return
+73.67%
5 Year Return
+135.73%
10 Year Return
+381.42%
AUM
$8.39B
AUM Growth
-$519M
(-5.8%)
Cap. Flow
-$200M
Cap. Flow
% of AUM
-2.38%
Top 10 Holdings %
Top 10 Hldgs %
24.75%
Holding
333
New
16
Increased
81
Reduced
102
Closed
21
Top Buys
| 1 |
Chewy
CHWY
|
$71.6M |
| 2 |
WAY
Waystar Holding Corp
WAY
|
$53.6M |
| 3 |
GFL Environmental
GFL
|
$51.1M |
| 4 |
SMAR
Smartsheet Inc.
SMAR
|
$49.1M |
| 5 |
Madrigal Pharmaceuticals
MDGL
|
$42.9M |
Top Sells
| 1 |
Matsons
MATX
|
$122M |
| 2 |
LPL Financial
LPLA
|
$120M |
| 3 |
Kirby Corp
KEX
|
$69.9M |
| 4 |
Merit Medical Systems
MMSI
|
$44.2M |
| 5 |
Grand Canyon Education
LOPE
|
$37.4M |
Sector Composition
| 1 | Healthcare | 25.58% |
| 2 | Technology | 24.6% |
| 3 | Industrials | 16.21% |
| 4 | Consumer Discretionary | 16.13% |
| 5 | Communication Services | 5.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Bank of America
BAC
$369B
| $3.43M | 0.04% |
86,350
-73,000
| -46% | -$2.9M |
|
227
Liberty Global Class A
LBTYA
$4.05B
| $3.16M | 0.04% |
181,200
| – | – |
|
|
RDUS
228
DELISTED
Radius Recycling
RDUS
| $3.02M | 0.04% |
+198,000
| New | +$3.02M |
|
229
Pliant Therapeutics
PLRX
$114M
| $3.02M | 0.04% |
281,189
| – | – |
|
230
Vaxcyte
PCVX
$4.29B
| $3.02M | 0.04% |
40,000
| – | – |
|
231
Digital Realty Trust
DLR
$55.7B
| $2.86M | 0.03% |
18,817
| – | – |
|
232
BridgeBio Pharma
BBIO
$10.2B
| $2.79M | 0.03% |
110,011
| – | – |
|
233
MP Materials
MP
$11.2B
| $2.69M | 0.03% |
211,000
-93,000
| -31% | -$1.18M |
|
234
Planet Labs
PL
$1.98B
| $2.64M | 0.03% |
1,417,000
+143,000
| +11% | +$266K |
|
235
Liberty Media Series A
FWONA
$22.6B
| $2.62M | 0.03% |
40,724
| – | – |
|
236
Qualcomm
QCOM
$172B
| $2.57M | 0.03% |
12,900
-700
| -5% | -$139K |
|
|
LSXMA
237
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $2.38M | 0.03% |
107,478
| – | – |
|
238
Inhibrx
INBX
$408M
| $2.16M | 0.03% |
+152,159
| New | +$2.16M |
|
239
Viking Therapeutics
VKTX
$3.03B
| $2.12M | 0.03% |
39,923
-8
| -0% | -$424 |
|
240
Insmed
INSM
$30.7B
| $2.01M | 0.02% |
+30,000
| New | +$2.01M |
|
241
D.R. Horton
DHI
$54.2B
| $1.99M | 0.02% |
14,100
| – | – |
|
242
Liberty Live Group Series C
LLYVK
$8.88B
| $1.91M | 0.02% |
49,948
| – | – |
|
243
Live Nation Entertainment
LYV
$37.9B
| $1.89M | 0.02% |
20,200
| – | – |
|
244
Brookfield Asset Management
BAM
$94B
| $1.86M | 0.02% |
48,844
| – | – |
|
245
Immunovant
IMVT
$2.99B
| $1.85M | 0.02% |
70,000
| – | – |
|
246
Brookfield Infrastructure
BIPC
$4.75B
| $1.79M | 0.02% |
53,181
-1,000
| -2% | -$33.7K |
|
247
Illumina
ILMN
$15.7B
| $1.64M | 0.02% |
15,700
-440
| -3% | -$45.9K |
|
248
Amazon
AMZN
$2.48T
| $1.57M | 0.02% |
8,114
| – | – |
|
249
Microsoft
MSFT
$3.68T
| $1.42M | 0.02% |
3,169
| – | – |
|
250
EVI Industries
EVI
$362M
| $1.35M | 0.02% |
71,193
-103,729
| -59% | -$1.96M |
|